Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | STS | P08842 | 7/20 | 0.78 |
| ▸ | ESR1 | P03372 | 3/20 | 0.76 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.76 |
| ▸ | CA1 | P00915 | 2/20 | 0.76 |
| ▸ | CA2 | P00918 | 2/20 | 0.76 |
| ▸ | CA9 | Q16790 | 2/20 | 0.76 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.76 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.76 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.76 |
| ▸ | CA4 | P22748 | 1/20 | 0.76 |
| ▸ | CA6 | P23280 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15308964 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL12441050 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL5017878 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL5682139 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL4570835 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL10079402 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL5677806 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL18658723 | 1.00 | HSD17B1 (1.00) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| Ethylene SCHEMBL11570544 | 0.98 | HSD17B1 (0.95) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 | |
| SCHEMBL3872024 | 0.93 | HSD17B1 (0.87) | HSD17B1LMNAMAPTRECQLSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111032024-A | Bioerodible drug delivery implant | 赫拉健康解决方案公司 | 2020-04-17 | — | — | CN | claimed |
| EP-1831144-B1 | A NEW PROCESS FOR THE PREPARATION OF PHENOLIC HYDROXY-SUBSTITUTED COMPOUNDS | RICHTER GEDEON NYRT (HU) | 2011-08-17 | — | — | EP | claimed |
| US-7973185-B2 | Process for the preparation of phenolic hydroxy-substituted compounds | RICHTER GEDEON NYRT. (HU) | 2011-07-05 | — | — | US | claimed |
| US-20080039643-A1 | Process for the Preparation of Phenolic Hydroxy-Substituted Compounds | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 2008-02-14 | — | — | US | claimed |
| EP-1831144-A2 | A NEW PROCESS FOR THE PREPARATION OF PHENOLIC HYDROXY-SUBSTITUTED COMPOUNDS | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 2007-09-12 | — | — | EP | claimed |
| WO-2006061666-A2 | A NEW PROCESS FOR THE PREPARATION OF PHENOLIC HYDROXY-SUBSTITUTED COMPOUNDS | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 2006-06-15 | — | — | WO | claimed |
| CN-1036833-C | Contraceptive regimen | AKZO NV (NL) | 1997-12-31 | — | — | CN | claimed |
| EP-0182808-A1 | 17 a?$g(b)-HYDROXY-7$g(a)-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES | SRI INTERNATIONAL (US) | 1986-06-04 | — | — | EP | claimed |
| WO-1985005361-A1 | 17abeta-HYDROXY-7alpha-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES | SRI INTERNATIONAL (US) | 1985-12-05 | — | — | WO | claimed |
| EP-0037973-B1 | PROCESS FOR THE SYNTHESIS OF ESTRONE OR ESTRONE DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-05-30 | — | — | EP | claimed |
| JP-55020746-A | — | — | None | — | — | JP | disclosed |
| JP-5178884-A | — | — | None | — | — | JP | disclosed |
| CN-122055369-A | Bridged tricyclic carbamoyl pyridone compounds and uses thereof | 吉利德科学公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122055373-A | Bridged tricyclic carbamoyl pyridone compounds and uses thereof | 吉利德科学公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-114245807-B | FLT3L-FC fusion proteins and methods of use | 吉利德科学公司 | 2025-05-02 | — | — | CN | disclosed |
| US-3960842-A | Process for the preparation of 17β-oxalyl steroids | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
| US-3956348-A | Steroid ether splitting | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3952018-A | 15-Oxasteroids | HOFFMANN-LA ROCHE INC. (US) | 1976-04-20 | — | — | US | disclosed |
| US-3933870-A | Synthesis of A-ring aromatic steroids | HOFFMANN-LA ROCHE INC. (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932519-A | 7,7A-Dihydro-4-[2-(3-alkoxyphenyl)-2-hydroxyethyl]-7a-alkyl-1, 5(6H)-indandiones,3,4,8,8a-tetrahydro-5-[2-(3-alkoxyphenyl)-2-hydroxyethyl]-8a-alkyl-1,6(7H)-naphthalenediones and processes for the preparation thereof utilizing asymmetric induction | HOFFMANN-LA ROCHE INC. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039643-A1 | Process for the Preparation of Phenolic Hydroxy-Substituted Compounds | NR3C2, CYP21A2, NR5A1 | HSD17B1 23/4885LMNA 3652/4885MAPT 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.